Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months

<p>Abstract</p> <p>Background</p> <p>Development and deployment of an effective malaria vaccine would complement existing malaria control measures. A blood stage malaria vaccine candidate, Merozoite Surface Protein-3 (MSP3), produced as a long synthetic peptide, has bee...

Full description

Bibliographic Details
Main Authors: Segeja Method D, Minja Daniel, Rutta Acleus, Sembuche Samwel, Seth Misago, Lemnge Martha, Francis Filbert, Msham Salum, Gesase Samwel, Lusingu John PA, Bosomprah Samuel, Cousens Simon, Noor Ramadhani, Chilengi Roma, Druilhe Pierre
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/8/1/163

Internet

http://www.malariajournal.com/content/8/1/163

Similar Items